Vir Biotechnology Inc (NAS:VIR)
$ 11.23 -0.75 (-6.26%) Market Cap: 1.53 Bil Enterprise Value: 601.30 Mil PE Ratio: 0 PB Ratio: 1.05 GF Score: 55/100

Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 11, 2022 / 03:00PM GMT
Release Date Price: $21.75 (-1.89%)
Joey Stringer
Needham & Company, LLC - Analyst

Good morning, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer; I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Vir Biotechnology. And joining us today from Vir is CMO, Phil Pang. (Conference Instructions)

And with that, we'll get started. I'll turn it over to Phil for some brief opening remarks, and then we'll go ahead and get started with the chat.

Phil Pang
Vir Biotechnology, Inc. - EVP & Chief Medical Officer

Joey, thank you so much. And as always, I want to begin by a disclaimer that I will be making some forward-looking statements and that for additional details, you should see our SEC filings.

So, Joey, just to begin, this is really an extraordinary and pivotal time for Vir, and I really want to emphasize that. In just five years since we were founded, we've brought a transformative life-saving medication to patients called sotrovimab, which is our COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot